Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators

Recruiting

• Conditions: Hepatocellular Carcinoma; Peritoneal Carcinoma
• Interventions: Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.

• Registration Number: NCT05932719
• Lead Sponsor: Hospices Civils de Lyon

Brief Summary

The COVID-19 pandemic has deeply and globally impacted usual procedures and patients management in cancer centers. The aim of this study is to set-up and collect indicators to follow-up the activities of different cancer pathologies before and during the pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to care (surgery, antineoplastic treatments).

Data collection will focus on the analysis of 2 specific pathologies for French patients in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-12-01
• Primary Completion: 2022-12-01
• Status Verified: 2023-07
• Study First Submitted: 2023-07-04
• Study First Submitted QC: 2023-07-04
• Study First Posted: 2023-07-06
• Last Update Submitted: 2023-07-07
• Last Update Posted: 2023-07-10
• Study Completion: 2024-12-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 4000

Inclusion Criteria

• Patients hospitalized in France for peritoneal carcinosis or hepatocellular carcinoma between 2017 and 2020.

Exclusion Criteria

• Patients who did not allow the reuse of their medical data for research

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Hepatocellular Carcinoma	COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.	Patients hospitalized for hepatocellular carcinoma between 2017 and 2020.
Peritoneal Carcinosis	COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.	Patients hospitalized for peritoneal carcinosis between 2017 and 2020.

Primary Outcome Measures

Name	Time	Method
Measure of patient loss of chance when comparing a set of activity indicators between 2020 and the average activities of previous periods (2017-2019)	24 months	The difference between a set of different activity indicators will be compared between 2020 and the average activities of previous periods (2017-2019)

Trial Locations

Locations (1)

Hopital Lyon sud, Hospices civils de Lyon; 🇫🇷 Pierre-Bénite, France